Global Demand for Food & Pharmaceutical Grade Silica Surges in 2026, Three Segments Drive Overseas Growth

Since the start of 2026, global demand for high-purity silicon dioxide across food, dietary supplement and pharmaceutical sectors has seen explosive growth. Industry data shows food grade silica is outpacing all other segments with a 4.9% CAGR, emerging as a robust growth driver in the industrial raw materials space. On the application side, three core segments are fueling the upward trend: First, in food processing, amid the clean label movement, precipitated amorphous silica as a GRAS anti-caking agent is replacing traditional synthetic additives, appearing in 8% of new clean label products worldwide. Second, in the dietary supplement sector, expanding production of capsules and tablets has driven rising procurement of pharmaceutical grade silica as a glidant and carrier. Third, in pharmaceutical manufacturing, the shift of generic and biosimilar production to Asia-Pacific has widened the supply gap for high-purity pharmaceutical excipients. Geographically, North America and Europe maintain steady rigid demand as mature markets, while emerging manufacturing hubs in Southeast Asia and Latin America are growing much faster than the global average. On the supply side, certified Chinese suppliers with FDA GRAS, EP and USP approvals are becoming a core alternative for global buyers thanks to stable capacity and strong cost performance.